My Honest 6-Month Compounded Tirzepatide Story
My Honest 6-Month Compounded Tirzepatide Story is best understood as a clinical decision topic, not a shortcut. The evidence, pharmacy source, dose plan, contraindications, and follow-up matter more than any single success story online.
I started compounded tirzepatide in November of last year weighing 247 pounds. Six months later, I weighed 198. What follows is the unedited version of how that happened, written down because three friends asked me the same questions in the same week and I got tired of typing the same answers into different text threads.
Standard disclaimer first: compounded tirzepatide is not FDA-approved. The branded versions, Mounjaro and Zepbound, are approved for specific indications. Compounded preparations are prepared by licensed 503A/503B compounding pharmacies for individual patients based on prescriber clinical judgment, which is the framework I went through. None of what follows is medical advice. Talk to a clinician.
Why I Started
I had been overweight since college. By my late thirties, I had picked up the standard metabolic starter pack: borderline blood pressure, fasting glucose creeping toward prediabetic territory, a sleep apnea diagnosis the year before. My primary care doctor had been gently raising the GLP-1 conversation for about a year. I kept deflecting because I knew my own pattern. I’d read enough cycling-through-diets research to recognize myself in every graph.
The thing that finally moved me was watching my dad, who is built like I am, navigate a cardiac scare last spring. He had a stent placed at 64. I sat with him in the cafeteria at St. Luke’s while he ate Jell-O and told me, in the flat voice of a man who’d just had a wire threaded through his femoral artery, “I wish I’d tried those new shots when they came out. I was too proud.” That conversation rearranged my priorities in about ninety seconds.
How I Picked a Provider
I spent two weeks reading. I looked at four telehealth providers, including the big-name ones, and the in-person obesity medicine clinic in my city. The in-person clinic had a six-month waitlist and was out of network. The big-name telehealth shops felt fine, but they ran on monthly subscriptions where I wouldn’t own my prescription if I wanted to switch. That felt like a gym membership designed to be hard to cancel.
I ended up going with FormBlends for three reasons. They were straightforward about the compounded status of the medication, including the not-FDA-approved framing, which actually made me trust them more rather than less. The pricing was transparent. And the prescriber consult was actually a consult, not a thirty-second checkbox exercise where someone confirms you have a pulse and a credit card.
The First Injection and the Kitchen Audience
I started at 2.5 mg weekly, the standard induction dose. The first injection was on a Sunday evening. I did it in the kitchen while my wife watched with the same expression she wears when I’m about to do something with a power tool.
Side effects in week one were mild. Some nausea on Tuesday morning that passed by mid-afternoon. A subtle shift in appetite that I noticed mostly because food smells stopped pulling me into the kitchen the way they normally did. I lost three pounds that first week, which I now know was mostly water.
Weeks two through four were uneventful. I held at 2.5 mg per protocol. Total loss for month one: seven pounds.
What Actually Changed at 5 mg
Month two, I went up to 5 mg. This is where things shifted in a way that felt qualitatively different. The constant background hum of food thinking, which I had assumed was just how human brains operated, quieted down.
I want to be precise here because the language around GLP-1 medications tends to drift toward either miracle or scam, and neither captures it. I did not become uninterested in food. I still enjoyed meals. What changed was the loop between an environmental cue (driving past a restaurant, opening the fridge, smelling popcorn in a movie theater) and a craving. That loop got substantially weaker. The space between stimulus and impulse opened up. For the first time in twenty years, I could notice I wanted something and choose not to have it without white-knuckling through the next hour.
I titrated to 7.5 mg at month three and stayed there for the remainder of the six months. My prescriber and I discussed going higher and decided against it because the rate of loss at 7.5 was already at the upper end of what’s considered safe and sustainable.
What I Actually Ate
No specific diet. I focused on protein at every meal because I’d read the muscle-loss research and wanted to mitigate that risk. My target was around 130 grams of protein per day, roughly 1.2 grams per kilogram of target body weight, which is what the obesity medicine literature suggests for patients on GLP-1 agonists.
Plate volume dropped naturally. By month three I was eating roughly 60 percent of what I ate before starting. I didn’t count calories. I tracked protein and let everything else float.
The foods that worked best combined high protein density with low total volume: Greek yogurt, chicken breast, eggs, cottage cheese, lean fish. The foods that didn’t work were, predictably, my old favorites. Fatty cuts of meat, fried anything, heavy restaurant meals. These triggered nausea like clockwork. There’s a certain irony in a medication that makes the foods most responsible for your weight gain the ones your body now rejects.
Walking. That’s the Whole Answer.
I walked thirty to forty-five minutes every day, usually in the morning before work. I lifted weights twice a week, light by my pre-medication standards, focused on the major compound movements (squat, deadlift, row, press).
That’s it. No HIIT circuits. No spin classes. I was deliberate about not stacking an aggressive exercise deficit on top of the appetite suppression, because the literature is clear: combined aggressive deficits during GLP-1 treatment accelerate lean mass loss. The boring truth is that walking and basic strength training, done consistently, was enough.
The Side Effects Nobody Warns You About
Constipation was the persistent one. Not severe, but a constant low-grade presence. I addressed it with fiber, water, and magnesium citrate at bedtime. It improved but never fully resolved.
Fatigue was the second. Not exhaustion, more like a reduced ceiling on daily capacity. By month four I’d adapted, partly through better sleep hygiene and partly through accepting that I was operating on fewer calories and my body was going to let me know about it.
The third was social, and this one caught me off guard. The first time I declined a second helping at my mother-in-law’s house, she asked if I was sick. The first time I left a beer half-finished at a friend’s place, the table went quiet for about three seconds. My buddy Dave, unprompted, said “You on that Ozempic stuff?” in the tone people used to reserve for asking if someone found Jesus.
These moments are individually small but they accumulate. Nobody prepares you for the social negotiation that comes with visibly losing weight on a medication that’s become a cultural flashpoint. You learn to have a short answer ready.
The Numbers
Starting weight: 247 pounds. Ending weight at six months: 198. Total loss: 49 pounds, or 19.8 percent of starting body weight.
This lands at the high end of what clinical trial data would predict. The SURMOUNT-1 study reported average loss of around 20 percent at the higher doses over roughly 72 weeks. I got there in 26 weeks. Some of that is probably the higher motivation of a self-selected patient paying out of pocket. Some is probably the specific dose progression. Some is probably individual biological responsiveness, which research suggests varies considerably between patients. I’m not claiming my results are typical. I am claiming they’re real.
Blood pressure dropped from 138/86 to 122/76. Fasting glucose dropped from 104 to 88. Resting heart rate dropped from 72 to 64. I haven’t had a sleep study redone yet, but the apnea symptoms are noticeably better and my wife says the snoring has dropped to “tolerable” (her word).
Maintenance and the Long Game
I dropped to 5 mg for the maintenance phase, which is where I am now. My weight is stable at 198. I’ll probably continue to lose slowly over time. My goal is around 185, but I’m not in a hurry.
Here’s the thing: the maintenance question is the one I think about most. The long-term data on staying on these medications is still being collected. We have strong 72-week data from the SURMOUNT trials. We have emerging real-world evidence. We don’t have ten-year data, because the drugs haven’t existed for ten years. That’s a genuine uncertainty, and anyone who tells you otherwise is selling something.
My plan is to stay on a maintenance dose for at least the next year and reassess with my prescriber. That feels like informed caution rather than recklessness.
Would I Do It Again
Yes. Without hesitation.
The honest, complete answer includes caveats: the medication doesn’t do the work of restructuring your relationship with food, movement, and sleep. All of that still has to happen. You still have to make decisions every single day.
But what the medication did for me was quiet the biology enough that the behavioral work I had failed at for twenty years became possible. It took a willpower problem and turned it into a logistics problem. And logistics problems, unlike willpower problems, are solvable.
That’s what it did. Nothing more. Nothing less.
Frequently Asked Questions
How much does compounded tirzepatide typically cost? Pricing varies by provider and dose. I paid between $350 and $450 per month depending on the dose level during titration. Maintenance at 5 mg currently runs me about $350 per month. This is meaningfully less than branded Mounjaro or Zepbound without insurance coverage, which can run $1,000+ monthly.
Is compounded tirzepatide the same as Mounjaro? Not exactly. Compounded tirzepatide contains the same active ingredient (tirzepatide) but is prepared by compounding pharmacies rather than the original manufacturer (Eli Lilly). Compounded versions are not FDA-approved and may differ in inactive ingredients, delivery device, or formulation. This is an important distinction to understand before starting.
How long do side effects last? For me, nausea was primarily a first-week phenomenon that returned mildly with each dose increase. Constipation persisted throughout but was manageable. Fatigue improved significantly by month four. Most clinical data suggests GI side effects are most pronounced during the titration period and diminish with time, though individual experiences vary.
Can you drink alcohol on tirzepatide? You can, technically. I found that my tolerance dropped significantly and that alcohol on a reduced-calorie intake hit harder and faster. I went from a couple of beers on weekends to maybe one, and even that sometimes triggered nausea. My prescriber advised moderation rather than abstinence, but many patients find they naturally drink less.
What happens if you stop taking it? The SURMOUNT-3 and SURMOUNT-4 extension studies showed that patients who discontinued tirzepatide regained a significant portion of lost weight over the following year. This is consistent with the broader obesity medicine understanding that obesity is a chronic condition requiring ongoing treatment, not a problem you fix once and walk away from. My current plan is to stay on a maintenance dose indefinitely.
Do you need to exercise while on tirzepatide? You should. Resistance training in particular helps preserve lean mass during weight loss, which is important because GLP-1-mediated weight loss, like all weight loss, involves some muscle loss alongside fat loss. The literature consistently supports combining these medications with structured physical activity and adequate protein intake for the best body composition outcomes.
How do I find a legitimate compounded tirzepatide provider? Look for providers who are transparent about compounded status, work with licensed 503A or 503B compounding pharmacies, and offer real clinical consultations rather than auto-approval pathways. I went with FormBlends after comparing several options and verifying their practices. Do your own due diligence, read their clinical approach documentation, and make sure a licensed prescriber is evaluating your medical history before anything is prescribed.
